Kyoto Drug Discovery & Development Co., Ltd. – Trademark Portfolio

Entity Type: 03

Kyoto Drug Discovery & Development Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RETICEP.

#302, Saito Bio Hills Center

7-7-18, Saitoasagi, Ibaraki-shi Osaka 567-0085

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ATCERICH
ATCERICH
Abandoned 2022
RETICEP
RETICEP
Registered 2022
VISCKET
VISCKET
Abandoned 2022

Trademark Classifications

Kyoto Drug Discovery & Development Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Kyoto Drug Discovery & Development Co., Ltd. have?

Kyoto Drug Discovery & Development Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Kyoto Drug Discovery & Development Co., Ltd. file in?

Kyoto Drug Discovery & Development Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Kyoto Drug Discovery & Development Co., Ltd.'s most well-known trademarks?

Kyoto Drug Discovery & Development Co., Ltd.'s registered trademark portfolio includes well-known marks such as RETICEP. These are among 1 currently registered trademark in the portfolio.

What is Kyoto Drug Discovery & Development Co., Ltd.'s trademark registration success rate?

Kyoto Drug Discovery & Development Co., Ltd. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.